title: Erythropoietin-associated hypertension: what role for blood viscosity changes?
authors.forename: B
authors.initials: B
authors.lastname: Canaud
authors.forename: P
authors.initials: P
authors.lastname: Donadieu
authors.forename: C
authors.initials: C
authors.lastname: Polito
authors.forename: J P
authors.initials: JP
authors.lastname: Rivory
authors.forename: J C
authors.initials: JC
authors.lastname: Mathieu-Daudé
authors.forename: F
authors.initials: F
authors.lastname: Peterlongo
authors.forename: C
authors.initials: C
authors.lastname: Mion
mesh_terms: D000740:Anemia / Q000628:therapy; D001809:Blood Viscosity; D004921:Erythropoietin / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000139:chemically induced*; D006435:Renal Dialysis
chemical_list: D004921:Erythropoietin